Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1689180

registered interest
date	16/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Shortages
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what comparative assessment she has made of trends in the total number of medicine shortages recorded by her Department in January (a) 2021, (b) 2022, (c) 2023 and (d) 2024.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	14113
answer	answer is ministerial correction date of answer 27/02/2024 answer text <p>There are around 14,000 licensed medicines, and the overwhelming majority are in good supply. However, the medicine supply chain is highly regulated, complex and global, and supply disruption is a common issue which affects countries all around the world.</p><p>The Department’s medicine Discontinuations and Shortages portal has been collecting notifications from suppliers of potential supply issues since October 2020, and shows that there were approximately:</p><p>- 90 supply issue notifications in January 2021;</p><p>- 110 supply issue notifications in January 2022;</p><p>- 170 supply issue notifications in January 2023; and</p><p>- 160 supply issue notifications in January 2024.</p><p>Although reporting does vary each month, annual notifications have remained fairly stable at approximately 1,600 supply issue notifications in 2022 and 2023. It is important to note that not all supply issue notifications will lead to a medicine shortage.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 27/02/2024 11:24:53 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4623 label Biography information for Tonia Antoniazzi

424864

registered interest
date	29/10/2015
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Save as You Earn
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, what recent estimate he has made of how many low and middle income earners save and invest in a save-as-you-earn employee share plan.
tabling member constituency	Sheffield, Heeley
tabling member printed	Louise Haigh
uin	14113
answer	answer is ministerial correction date of answer 06/11/2015 answer text <p>The tax-advantaged Save As You Earn (SAYE) and Share Incentive Plan (SIP) limits were significantly increased from April 2014. The increases the Government have made are reasonable, given the average monthly SAYE savings and the value of awards currently made to employees under SIP, and they represent the best use of resources. The Government will continue to keep the SAYE and SIP limits under review.</p><br /><p>In addition to increasing the SAYE and SIP limits, the rules of the schemes were substantially reviewed and simplified following the recommendations made by the Office of Tax Simplification in March 2012. Last year, the requirement that these schemes must be approved by HM Revenue and Customs to qualify for favourable tax treatment was replaced by self-certification. Coupled with other changes to simplify some technical aspects of the rules, this will make these schemes more attractive to businesses and employees.</p><br /><p>No data is collected and no estimates are made of the income levels of the participants in SAYE schemes.</p><br /><p>Permitting private equity backed companies to offer all-employee tax advantaged schemes would be likely to involve significant changes to the rules of the schemes, and there would be a number of other factors to consider carefully, including the increased cost and complexity of any extension.</p><br /> answering member constituency South West Hertfordshire answering member printed Mr David Gauke grouped question UIN 14110 14111 14112 question first answered 06/11/2015 13:46:29 answering member 1529 label Biography information for Mr David Gauke
tabling member	4473 label Biography information for Louise Haigh